Up-regulation of interleukin-9 and the interleukin-9-associated calcium-activated chloride channel hCLCA1 in nasal mucosa following in vivo allergen challenge

Allergy, Asthma and Clinical Immunology

Volumn 3, Issue 1, 2007, Pages 19-23

  Hauber, Hans Peter ^a   Bergeron, Celine ^a   Toda, Masao ^a   Kontolemos, Mario ^a   Holroyd, Kenneth J ^b   Levitt, Roy C ^b   Hamid, Qutayba ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Genaera Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED CHLORIDE CHANNEL; CALCIUM ACTIVATED CHLORIDE CHANNEL HCLCA1; CHLORIDE CHANNEL; INTERLEUKIN 9; RAGWEED ANTIGEN; UNCLASSIFIED DRUG;

ALLERGIC RHINITIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; EOSINOPHIL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PROCEDURES; IN SITU HYBRIDIZATION; IN VIVO STUDY; NASAL BIOPSY; NOSE MUCOSA; PRICK TEST; PROTEIN EXPRESSION; RAGWEED; RESPIRATORY EPITHELIUM; T LYMPHOCYTE; UPREGULATION;

EID: 34247463442     PISSN: 17101484     EISSN: None     Source Type: Journal    
DOI: 10.2310/7480.2006.00015     Document Type: Article

References (17)

1. Nicolaides NC, Holroyd KJ, Ewart SL, et al. Interleukin 9: a candidate gene for asthma. Proc Natl Acad Sci U S A 1997;94: 13175-80.
2. Shimbara A, Christodoulopoulos P, Soussi-Gounni A, et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 1999;104: 108-15.
3. McLane MP, Haczku A, van Rijn M, et al. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyperresponsiveness in transgenic mice. Am J Respir Cell Mol Biol 1998; 19:713-20.
4. Dong Q, Louahed J, Vink A, et al. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol 1999;29:2130-9.
5. Temann UA, Ray P, Flavell RA. Pulmonary over-expression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Invest 2002;109:29-39.
6. Louahed J, Toda M, Jen J, et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol 2000;22:649-56.
7. Longphre M, Li D, Gallup M, et al. Allergeninduced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest 1999;104:1375-82.
8. Little F, Cruikshank WW, Center DM. IL-9 stimulates release of chemotactic factors from human bronchial epithelial cells. Am J Respir Cell Mol Biol 2001;25:347-52.
9. Zhou Y, Dong Q, Louahed J, et al. Characterization of a calcium-activated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol 2001;25:486-91.
10. Nakanishi A, Morita S, Iwashita H, et al. Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci U S A 2001;98:5175-80.
11. Toda M, Tulic MK, Levitt RC, Hamid Q. A calcium-activated chloride channel (hCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol 2002;109:246-50.
12. Hamid Q, Wharton J, Terenghi G, et al. Localization of atrial natriuretic peptide mRNA and immunoreactivity in the rat heart and human atrial appendage. Proc Natl Acad Sci U S A 1987;84: 6760-4.
13. Hamid Q, Azzawi M, Ying S, et al. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991;87:1541-6.
14. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
15. Varney VA, Jacobson MR, Sudderick RM, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 1992;146:170-6.
16. Ying S, Meng Q, Kay AB, Robinson DS. Elevated expression of interleukin-9 mRNA in bronchial mucosa of atopic asthmatics and allergen-induced cutaneous late-phase reaction: relationships to eosinophils, mast cells and T lymphocytes. Clin Exp Allergy 2002; 32:866-71.
17. Nakona T, Inoue H, Fukuyama S, et al. Niflumic acid suppresses interleukin-13-induced asthma phenotypes. Am J Respir Crit Care Med 2006 Mar 9 [Epub ahead of print].